ESMO: AlphaMedixTM phase 2 data support first-in-class potential of new targeted alpha therapy in gastroenteropancreatic neuroendocrine tumors New AlphaMedix data showed sustained and clinically ...
New AlphaMedix data showed sustained and clinically meaningful responses across both RLT-naïve and RLT-exposed patients with unresectable or metastatic GEP-NETsFirst phase 2 study to evaluate TAT with ...
Wrap Technologies, Inc. is becoming an end-to-end safety platform with BolaWrap, body cams with AI & VR training. Learn more ...
Q3 2025 Earnings Call October 21, 2025 4:30 PM EDTCompany ParticipantsGregory Lundberg - Senior Vice President of ...
Cryptopolitan on MSN
Hyperliquid founder dismisses revenue-focused claims as FUD
Hyperliquid founder denied claims that the platform focuses on revenue, saying its ADL events made users hundreds of millions ...
ZeroBase and YieldBasis are set to launch on Binance, but traders are eyeing DSNT. Up 24% and priced at $0.01877, the presale ...
Alabama football changed the injury status of running back Jam Miller in a positive direction. Miller is now listed as probable on the Thursday night availability report. Miller had been listed as ...
The Crimson Tide clinched bowl eligibility for the 22nd consecutive season following its home victory against the Volunteers.
Yei Finance’s native token CLO has seen an explosive debut, soaring by over 300% within its hours and outpacing the broader ...
Webus International integrates XRP settlement into a tokenized travel rewards exchange, targeting the $20 billion loyalty ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback